Ana I. Velázquez Mañana: Lung Cancer management updates from 2024 by Weill Cornell Medicine Meyer Cancer Center

Ana I. Velázquez Mañana shared a post on X:

”Christine Garcia from Weill Cornell Medicine Meyer Cancer Center provides a fantastic and comprehensive review of the many Lung Cancer management updates from 2024.

An Eras Tour from ASCO Lung to WCLC 2024 covering key approvals in early stage and advanced NSCLC such as AEGEAN, ALINA, LAURA, FLAURA2, MARIPOSA, MARIPOSA2, CROWN, updates in SCLC, and more!”

Source: Ana I. Velázquez Mañana/X

Ana Velázquez Mañana is an Assistant Professor of Medicine in the UCSF Division of Hematology/Oncology at Zuckerberg San Francisco General and a thoracic oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center. She serves as Assistant Director of Diversity, Equity, Inclusion, and Accessibility for Trainees of the UCSF Helen Diller Family Comprehensive Cancer Center and co-chairs the UCSF Department of Medicine Fellowship Diversity Committee. Her research, advocacy, and education efforts are focused on promoting and advancing health equity and workforce diversity.